<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Asian J Neurosurg</journal-id><journal-id journal-id-type="publisher-id">AJNS</journal-id><journal-title-group><journal-title>Asian Journal of Neurosurgery</journal-title></journal-title-group><issn pub-type="ppub">1793-5482</issn><issn pub-type="epub">2248-9614</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22347327</article-id><article-id pub-id-type="pmc">3277073</article-id><article-id pub-id-type="publisher-id">AJNS-6-72</article-id><article-id pub-id-type="doi">10.4103/1793-5482.92160</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Inhibition of activated <italic>NR2B</italic> gene- and caspase-3 protein-expression by glutathione following traumatic brain injury in a rat model</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Arifin</surname><given-names>Muhammad Zafrullah</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Faried</surname><given-names>Ahmad</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Shahib</surname><given-names>Muhammad Nurhalim</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Wiriadisastra</surname><given-names>Kahdar</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bisri</surname><given-names>Tatang</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran&#x02013;Dr. Hasan Sadikin Hospital, Bandung, Indonesia</aff><aff id="aff2"><label>2</label>Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran&#x02013;Dr. Hasan Sadikin Hospital, Bandung, Indonesia</aff><aff id="aff3"><label>3</label>Department of Biochemistry, Faculty of Medicine, Universitas Padjadjaran&#x02013;Dr. Hasan Sadikin Hospital, Bandung, Indonesia</aff><aff id="aff4"><label>4</label>Department of Anesthesiology, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Bandung, Indonesia</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Ahmad Faried, Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran&#x02013;Dr. Hasan Sadikin Hospital, Jl Pasteur 38, Bandung 40161, Indonesia. E-mail: <email xlink:href="faried.fkup@gmail.com">faried.fkup@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Dec</season><year>2011</year></pub-date><volume>6</volume><issue>2</issue><fpage>72</fpage><lpage>77</lpage><permissions><copyright-statement>Copyright: &#x000a9; Asian Journal of Neurosurgery</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background.</title><p>Traumatic brain injury (TBI) remains a major cause of death and disability. Oxidative stress is an important element of the injury cascade following TBI. Progressive compromise of antioxidant defenses and free radical-mediated lipid peroxidation are one of the major mechanisms of secondary TBI. <italic><bold>NR2B</bold></italic> is a glutamate receptor and its activation is caused by TBI increasing a brain cell death, along with caspase-3 as a hall mark of apoptosis. Glutathione is a potent free radical scavenger that might prevent secondary TBI damage and inhibited apoptosis.</p></sec><sec id="st2"><title>Materials and Methods.</title><p>In the present study, it aims to demonstrate the effect of glutathione on inhibition of brain oxidative damage in a TBI rat model.</p></sec><sec id="st3"><title>Results.</title><p>In this study, the expressions of mRNA <bold><italic>NR2B</italic></bold> in placebo group and groups with glutathione administration at 0, 3, and 6 hours after TBI were 328.14, 229.90, 178.50, and 136.14, respectively (<italic><bold>P</bold></italic>&#x0003c;0.001). The highest caspase-3 expression was shown in placebo group with 66.7% showing strong positive results (&#x0003e;80%); as expected, glutathione administered in 0, 3, and 6 hours groups had lower strong positive results of 50%, 16.7%, and 16.7%, respectively, (<italic><bold>P</bold></italic>=0.025).</p></sec><sec id="st4"><title>Conclusion.</title><p>In conclusion, this study showed that glutathione administration in a TBI rat model decreased <italic><bold>NR2B</bold></italic> gene- and caspase-3 protein-expression that lead to the inhibition of brain cell death. Our results suggest that glutathione, as a potent free radical scavenger, has a brain cell protective effect against oxidative damage and cell death induced by TBI in rat model.</p></sec></abstract><kwd-group><kwd>Caspase-3</kwd><kwd>glutathione</kwd><kwd><italic><bold>NR2B</bold></italic> gene</kwd><kwd>traumatic brain injury</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>Introduction</title><p>Traumatic brain injury (TBI) remains a major cause of death and disability with an estimated annual occurrence of 1.4 million cases in the United States.[<xref ref-type="bibr" rid="ref1">1</xref>] In Panti Nugroho Pakem Hospital, Yogyakarta, Indonesia, TBI cases were reported in the first quarter of year 2005, which ranked fifth of all visits to the emergency room and the second of all causes of hospitalization; of those cases, 17.8% was referred to the main-hospital with a mortality rate of 2.7%.[<xref ref-type="bibr" rid="ref2">2</xref>] The Department of Neurosurgery at Dr. Hasan Sadikin Hospital (RSHS), Bandung, Indonesia, received 1212 cases within the 11 months of 2000 or more than 100 cases/month. The incidence was increased by 11.6% (1352) in 2006. In August 2007, 258 out of 462 accident cases were TBI (44.2%).[<xref ref-type="bibr" rid="ref3">3</xref>]</p><p>TBI can be classified as primary, which occurs immediately following a trauma and continues to evolve during the subsequent hours and days after the initial insult in what is referred to as a secondary injury.[<xref ref-type="bibr" rid="ref4">4</xref>] Improved outcomes might be achieved by preventing or reducing the secondary injury. Limiting a secondary injury results in lower mortality rates, improved functional outcome scores, shorter hospital stay, and decreased charges.[<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref6">6</xref>]</p><p>Several pathogenetic mechanisms of secondary damage, including derangements in cerebral blood flow, excitotoxicity, reactive oxygen species (ROS), inflammation, and apoptosis have been described.[<xref ref-type="bibr" rid="ref7">7</xref>] Two signaling pathways for the initiation of apoptosis are well known: One is mediated by a dead receptor, which is called an &#x0201c;extrinsic pathway,&#x0201d; and the other, the &#x0201c;intrinsic pathway,&#x0201d; is mediated by mitochondria.[<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref>] In both pathways, the induction of apoptosis leads to the activation of initiator caspases: Caspase-8 for the extrinsic pathway, and caspase-9, which is activated at the apoptosome for the intrinsic pathway, which finally activates caspase's executor, caspase-3.[<xref ref-type="bibr" rid="ref10">10</xref>]</p><p>The <italic>N</italic>-methyl-D-aspartate (NMDA) receptor is a heteromeric ligand gated ion channel that interacts with multiple proteins.[<xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref12">12</xref>] NMDA receptors are composed of association of subunits that belong to two families: A single gene product (NR1) with eight splice variants and four different <italic>NR2</italic> subunits (<italic>NR2A, B, C, D</italic>) produced by a different gene.[<xref ref-type="bibr" rid="ref13">13</xref>] Within the brain, the <italic>NR1, NR2A</italic> and <italic>NR2B</italic> subunits are more prominent in cortical areas and the hippocampus than in white matter and cerebellum.[<xref ref-type="bibr" rid="ref14">14</xref>] On the other hand, the <italic>NR2B</italic> subunits are expressed at the highest levels in the hippocampus, cerebral cortex, and olfactory bulb.[<xref ref-type="bibr" rid="ref15">15</xref>] Recently, Liu <italic>et al</italic>., reported that activation of <italic>NR2B</italic>- containing NMDA receptor results in excitotoxicity and increasing neuronal apoptosis.[<xref ref-type="bibr" rid="ref16">16</xref>] These events are very important to promote a brain cell protection.</p><p>The exposure of oxidative stress such as free radicals has been suggested as a major cause of neural cell death following TBI.[<xref ref-type="bibr" rid="ref17">17</xref><xref ref-type="bibr" rid="ref18">18</xref>] The brain's antioxidant mechanisms include superoxide dismutase (SOD) which converts free radicals to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), and glutathione peroxidase which further metabolized H<sub>2</sub>O<sub>2</sub> to H<sub>2</sub>O and O<sub>2</sub>.[<xref ref-type="bibr" rid="ref19">19</xref>] Oxidative stress is harmful due to its high fatty acid content and proportionately large share of total body oxygen consumption.[<xref ref-type="bibr" rid="ref20">20</xref>] SOD over expression has a protective effect against ischemic injury.[<xref ref-type="bibr" rid="ref21">21</xref><xref ref-type="bibr" rid="ref22">22</xref>] Endogenous glutathione is up regulated in the brain in response to TBI to compensate the damage.[<xref ref-type="bibr" rid="ref23">23</xref>] We speculated that exogenous glutathione would be needed to prevent a secondary TBI damage and inhibit apoptosis.</p><p>The aim of the present study was to examine the effect of glutathione administration on the expressions of mRNA <italic>NR2B</italic> and caspase-3 as indicators of early apoptosis-sign after a brain injury on a TBI rat model. We hypothesized that glutathione administered shortly after brain injury has a protective effect against the long-term sequelae of TBI by inhibiting the expression of <italic>NR2B</italic> and caspase-3.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Animal studies</title><p>Specific pathogen-free adult male Wistar rats were obtained from Bandung Institute of Technology with standard of Animal Care Committee, Bandung, Indonesia. They were maintained on a standard laboratory feed in a 12-hour (h) light/dark cycle. This study was approved by the Animal Research Ethics Board of Universitas Padjadjaran, Bandung, Indonesia. After a one-week period of environmental adaptation, the rats (<italic>n</italic>=30) weighing~400 gm were divided into five groups: (A) Control: Without TBI and without treatment, (B) Placebo: With TBI and administration of NaCl 0.9% soon after TBI, (C) Glutathione 0 h: With TBI, administration of glutathione 10.8 mg soon after TBI, (D) Glutathione 3 h: TBI, administration of glutathione 10.8 mg 3 h after TBI, and (E) Glutathione 6 h: With TBI, glutathione 10.8 mg 6 h after TBI and euthanized 3 h later (<italic>n</italic>=6). Some parts of the brain were stored in RNA-later for subsequent RNA isolation and other parts of the brains were fixed in 10% formalin, 4 &#x003bc;m sections and processed for tissue staining.</p></sec><sec id="sec2-2"><title>Traumatic brain injury rat model</title><p>Male rats were anesthetized with pentotal intraperitoneally 40 mg/kg body weight. After a midline skin incision, a 5-7 mm craniotomy was made from 3 mm right posterior of the bregma and 2 mm right lateral to the midline. The animals were then subjected to TBI using a small iron bar, receiving a contact velocity of 571.17 Newton/mm<sup>2</sup>. The contact velocity is equal to a mild TBI.[<xref ref-type="bibr" rid="ref24">24</xref>] After the injury, the craniotomy was closed and the rats were returned to their cages.</p></sec><sec id="sec2-3"><title>Drug (Glutathione) administration</title><p>A total of 10.8 mg (0.018&#x000d7;600 mg) of glutathione (Tationil<sup>&#x000ae;</sup> 600 mg/4 ml from Roche, Italy) was injected intraperitoneally. For rats weighing~400 grams, this equals to 600 mg of glutathione for human (70 kg).</p></sec><sec id="sec2-4"><title>RNA isolation and cDNA synthesis</title><p>Total RNA was extracted from fresh brain tissue using an RNeasy Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The quantity of isolated RNA was measured using an ND-1000 Spectrophotometer (NanoDrop Tech Inc., Rockland DE). Template cDNA was synthesized from 13.5 &#x003bc;g of total RNA with an Omniscript Reverse Transcriptase kit (Qiagen, Hilden, Germany), Random Primer (hexadeoxyribonucleotide mixture, Takara, Shiga, Japan) and Ribonuclease Inhibitor (Porcine liver, Takara, Japan). Total RNA was reverse-transcribed with four units of Omniscript Reverse Transcriptase in a reaction volume of 20 &#x003bc;l (60 min at 37&#x000b0;C, 5 min at 93&#x000b0;C, and finally put on ice). The cDNA samples were stored at &#x02013;30&#x000b0;C until analysis.</p></sec><sec id="sec2-5"><title>Reverse transcription-polymerase chain reaction</title><p>Reverse transcription-polymerase chain reaction (RT-PCR) was performed with a one step system (Promega BioSci., San Luis, CA, USA) using NR2B primers described previously;[<xref ref-type="bibr" rid="ref25">25</xref>] forward: GGTAGCCATGAACGAGACTG and reverse: TTCACGAAGTCCTGGTAGCC. RT-PCR mix were subjected to RT for 45 min at 45&#x000b0;C, followed by inactivation of RT enzyme at 94&#x000b0;C (2 min) and PCR (40 cycles) consisted of 94&#x000b0;C (30 sec), 60&#x000b0;C (1 min), and 68&#x000b0;C (2 min) with final extension at 68&#x000b0;C (10 min). The products were then run on a 3% agarose gel. Densitometry was performed by using Adobe Photoshop (Apple Inc., Cupertino, CA, USA) acquisition and analysis by the Quantity One (BioRad Inc., Melville, NY, USA).</p></sec><sec id="sec2-6"><title>Immunohistochemistry for caspase-3</title><p>Immunohistochemical staining of anti-caspase-3 antibody was performed by streptoavidin-biotin as described previously.[<xref ref-type="bibr" rid="ref26">26</xref>] Sections of four mm thick were deparaffinized and incubated with fresh 0.3% hydrogen peroxide in methanol for 30 min at room temperature. The specimens were then incubated with anti-caspase-3 antibody (Biocare Medical, Concord, CA, USA) as the primer antibody at a 1:100 dilution. The specimens were counterstained with H and E. Negative controls were prepared by substituting normal mouse serum for each primary antibody: No detectable staining was evident. The degree of staining was scored as we previously described.[<xref ref-type="bibr" rid="ref26">26</xref>] The sections were evaluated by two investigators without the knowledge of the pathological background.</p></sec><sec id="sec2-7"><title>Statistical analysis</title><p>Statistical analysis was performed using the Stat View software (ver. 5.0, SAS Institute Inc., NC, USA). The differences were considered statistically significant when P value was &#x0003c;0.05 (ANOVA).</p></sec></sec><sec id="sec1-3"><title>Results</title><p>We examined the effects of glutathione treatment on a TBI rat model at the molecular level. Isolated RNA from the rats&#x02019; brains&#x02019; was then subjected to RT-PCR to observe <italic>NR2B</italic> gene at 341 base-pair (bp). <italic>NR2B</italic>, as shown in [Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>], was observed slightly in control brains (Group A, 96.25&#x000b1;20). In contrast, strong expressions were observed in placebo group (Group B, 328.14&#x000b1;24), as shown in [<xref ref-type="fig" rid="F3">Figure 3</xref>], and gradually decreased in three other treated groups (Group C, 229.9&#x000b1;41; Group D, 178.5&#x000b1;41; and Group E, 136.14&#x000b1;63), as shown in [Figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref>]. The results showed that NR2B gene expression gradually decrease from placebo group to glutathione treated groups (<italic>P</italic>&#x0003c;0.001; [<xref ref-type="fig" rid="F3">Figure 3</xref>]) in a time-dependent manner, it might be due to neurotoxicity-decreased (represented by decreased <italic>NR2B</italic> as glutamate receptors) effect which lead to the inhibition of brain cell death. Our results suggested that glutathione as a potent antioxidant had a brain cell protection in TBI.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>RT-PCR results of the <italic>NR2B</italic> gene expression. PCR products identified following RT-PCR of <italic>NR2B</italic> gene expression. The presence of 341 base pair (bp) fragment represents expression of <italic>NR2B</italic> in group A and group B (a)</p></caption><graphic xlink:href="AJNS-6-72-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Expression of <italic>NR2B</italic> in group B, C, D and E, respectively (b)</p></caption><graphic xlink:href="AJNS-6-72-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Densitometric estimation of <italic>NR2B</italic> in each group (c). For group-explanation see Materials and Methods. Line 1: DNA ladder marker 100 bp. Lanes 2-6: Six rats brain tissue in each group</p></caption><graphic xlink:href="AJNS-6-72-g003"/></fig><p>Furthermore, we observed caspase-3 expression in the cytoplasm of brain cells [Figures <xref ref-type="fig" rid="F4">4</xref> and <xref ref-type="fig" rid="F5">5</xref>]. Expression of caspase-3 was not observed in control brains (Group A). By comparison, strong expression of caspase-3 was observed in placebo group (Group B, 66.7% was strong positive &#x0003e;80%), as shown in [<xref ref-type="fig" rid="F4">Figure 4</xref>] and gradually decreased in three other treated groups (Group C, 50% was strong positive &#x0003e;80%; Group D, 16.7%; and Group E, 16.7%) as shown in [<xref ref-type="fig" rid="F5">Figure 5</xref>]. The results showed that caspase-3 protein expressions gradually decrease from placebo group to glutathione treated groups (<italic>P</italic>=0.025; <xref ref-type="table" rid="T1">Table 1</xref>). The expressions of caspase-3 on a TBI rat model treated with glutathione were significantly lower than the expressions observed among those in the placebo group; the presence of this antigen was found to be strongly associated with glutathione treatment (<italic>P</italic>=0.025; <xref ref-type="table" rid="T1">Table 1</xref>). Glutathione administered shortly after brain injury as a single dose of 10.8 mg prevented the increase in cell death (represented by decreased caspase-3 as hall mark of apoptosis) in traumatized brain hemispheres.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Immunohistochemistry results of the caspase-3 protein expression. The brown color represents a positive staining of caspase-3. Expression of caspase-3 in group A and group B (a)</p></caption><graphic xlink:href="AJNS-6-72-g004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p>Expression of caspase-3 in each group B, C, D and E, respectively (b). For group-explanation see Materials and Methods</p></caption><graphic xlink:href="AJNS-6-72-g005"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Distribution of caspase-3 protein expression in TBI rat model treated with Glutathione</p></caption><graphic xlink:href="AJNS-6-72-g006"/></table-wrap></sec><sec id="sec1-4"><title>Discussion</title><p>Our study demonstrated a temporal sequence of event following TBI, which included a mark increase of <italic>NR2B</italic> and caspase-3 expression levels in placebo group of TBI rat model, indicating that peroxidation of lipid membrane as well as oxidative stress produced by head trauma induced damage of Deoxyribonucleic acid (DNA) and proteins.[<xref ref-type="bibr" rid="ref27">27</xref>] The oxidative stress played a key role in mediating secondary brain injury induced cell death by TBI.[<xref ref-type="bibr" rid="ref24">24</xref><xref ref-type="bibr" rid="ref28">28</xref>] When the tissues are exposed to oxidative stress, they increase the activity and expression of antioxidant enzymes as a compensatory mechanism against free radical-mediated damage. Nevertheless, the increased activity of the antioxidant enzymes may be inadequate to counteract the potential damage in many conditions of oxidative stress.[<xref ref-type="bibr" rid="ref29">29</xref>] Moreover, antioxidant enzyme activities have been found to be diminished under highly elevated oxidative stress conditions as a result of molecular damage. On the other hand, over expression of the glutathione enzyme as one of the antioxidant and anti peroxidase which strongly decrease the cell death from brain injury.[<xref ref-type="bibr" rid="ref30">30</xref>]</p><p>The brain is particularly vulnerable to oxidative injury because of its high rate of oxygen consumption and intense production of reactive radicals. NMDA receptor (NMDAR), a glutamate receptor, mediates neural plasticity and synaptic transmission in the mammalian central nerves system and also neuronal cell death.[<xref ref-type="bibr" rid="ref31">31</xref><xref ref-type="bibr" rid="ref32">32</xref>] Recently, <italic>NR2B</italic> receptor was shown to have different roles in supporting neuron survival and mediating neuronal cell death and hence had the impacts on neurotoxicity of brain.[<xref ref-type="bibr" rid="ref16">16</xref>] Liu <italic>et al</italic>., reported that the activation of <italic>NR2B</italic>-containing NMDA receptor resulted in excitatoxicity and an increasing neuronal apoptosis.[<xref ref-type="bibr" rid="ref16">16</xref>] Shahib <italic>et al</italic>., showed that the increase of NR2B expression is needed at certain level otherwise it might induce apoptosis.[<xref ref-type="bibr" rid="ref25">25</xref>]</p><p>Nerve cell damage that is caused by the rupture of brain blood vessels is the result of excessive release of glutamate from nerve cells and glial (marked by increased of the <italic>NR2B</italic> expression) and not because of hypoxic or ischemic mechanism.[<xref ref-type="bibr" rid="ref33">33</xref>] Glutamate then activates at least three types of NMDA receptor (<italic>NR2B</italic>, Kainate, and AMPA). These receptos could increase intracellular Ca<sup>2+</sup> level.[<xref ref-type="bibr" rid="ref34">34</xref>] Since NMDA is paired with Ca<sup>2+</sup> channel, activation of both will be followed by an influx of Ca<sup>2+</sup>, sodium, water, and chloride into the intracellular-space causing cellular swelling or cytotoxic-edema.[<xref ref-type="bibr" rid="ref35">35</xref><xref ref-type="bibr" rid="ref36">36</xref>] The increasing level of intracellular Ca+ will increase H<sub>2</sub>O<sub>2</sub> (peroxide) as well. The above events will produce nitric oxide, ROS, cofactor caspases from mitochondria that activate caspase-3 as the executor caspase and eventually cause cell death.[<xref ref-type="bibr" rid="ref37">37</xref><xref ref-type="bibr" rid="ref38">38</xref>] The excessive release of glutamate induced exitatory which effect leads to a decrease in endogenous glutathione. Additional exogenous glutathione which acts as an antioxidant and anti peroxide will slow brain cell death process and prevent further damage in viable brain cells.</p></sec><sec id="sec1-5"><title>Conclusion</title><p>In conclusion, this study showed that glutathione administered as a single dose of 10.8 mg prevents the brain oxidative damage induced by TBI in the rats by inhibiting the expression of <italic>NR2B</italic> and caspase-3 expression. Our results suggest that glutathione must be administered shortly after brain injury since the therapeutic time window in brain injury is very narrow (between 3 to 6 hours). The outcome of this study is expected to encourage the progress of traumatic brain injury studies in Indonesia. Further studies will be needed to elucidate the adjuvant glutathione therapy mechanism in the clinical setup of TBI.</p></sec></body><back><ack><title>Acknowledgment</title><p>We thank Prof. Dr. med. Tri Hanggono Achmad and Prof. R. M. Padmo Santjojo for their expertise and fruitful discussion. This work has been partly supported by Universitas Padjadjaran's research grant-in-aids for Ahmad Faried.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Universitas Padjadjaran</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="webpage"><article-title>Centers for Disease Control and Prevention, National Center for Injury Prevention and Control</article-title><source>Traumatic Brain Injury</source><year>2006</year><date-in-citation>Last cited on 2011 Jun 12</date-in-citation><comment>Available from:
<uri xlink:type="simple" xlink:href="http://www.cdc.gov/ncipc/tbi/TBI.htm">http://www.cdc.gov/ncipc/tbi/TBI.htm</uri></comment></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijanarka</surname><given-names>A</given-names></name><name><surname>Dwiphrahasto</surname><given-names>I</given-names></name></person-group><article-title>Implementation of clinical governance: Indicator development of head injury clinic in emergency unit</article-title><source>J Health Serv Manage</source><year>2005</year><volume>8</volume><fpage>213</fpage><lpage>20</lpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Arifin</surname><given-names>MZ</given-names></name></person-group><article-title>Glutathione effect on glutamate receptor and cell death after traumatic brain injury</article-title><source>Doctorate Dissertation, Department of Neurosurgery</source><year>2010</year><publisher-loc>Bandung, Indonesia</publisher-loc><publisher-name>Universitas Padjadjaran</publisher-name></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakhry</surname><given-names>SM</given-names></name><name><surname>Trask</surname><given-names>AL</given-names></name><name><surname>Waller</surname><given-names>MA</given-names></name><name><surname>Watts</surname><given-names>DD</given-names></name></person-group><article-title>Management of brain injured patients by an evidence-based medicine protocol improves outcomes and decreases hospital charges</article-title><source>J Trauma</source><year>2004</year><volume>56</volume><fpage>492</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">15128118</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>S</given-names></name><name><surname>Bader</surname><given-names>MK</given-names></name><name><surname>Qureshi</surname><given-names>A</given-names></name><name><surname>Palmer</surname><given-names>J</given-names></name><name><surname>Shaver</surname><given-names>T</given-names></name><name><surname>Borzatta</surname><given-names>M</given-names></name><etal/></person-group><article-title>The impact on outcomes in a community hospital setting of using AANS Traumatic Brain Injury Guidelines</article-title><source>J Trauma</source><year>2001</year><volume>50</volume><fpage>657</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">11303160</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>SC</given-names></name><name><surname>Spettell</surname><given-names>CM</given-names></name></person-group><article-title>Delayed and progressive brain injury in children and adolescents with head trauma</article-title><source>Pediatr Neurosurg</source><year>1995</year><volume>23</volume><fpage>299</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">8743998</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name></person-group><article-title>Molecular steps of death receptor and mitochondrial pathways of apoptosis</article-title><source>Life Sci</source><year>2001</year><volume>69</volume><fpage>2957</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">11758823</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krammer</surname><given-names>PH</given-names></name></person-group><article-title>CD95 (APO-1/Fas)-mediated apoptosis: Live and let die</article-title><source>Adv Immunol</source><year>1999</year><volume>71</volume><fpage>163</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">9917913</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>I</given-names></name><name><surname>Kirchhoff</surname><given-names>S</given-names></name><name><surname>Krammer</surname><given-names>PH</given-names></name></person-group><article-title>Regulation of death receptor-mediated apoptosis pathways</article-title><source>Int J Biochem Cell Biol</source><year>2000</year><volume>32</volume><fpage>1123</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">11137452</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igney</surname><given-names>FH</given-names></name><name><surname>Krammer</surname><given-names>PH</given-names></name></person-group><article-title>Death and anti-death: Tumour resistance to apoptosis</article-title><source>Nat Rev Cancer</source><year>2002</year><volume>2</volume><fpage>277</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">12001989</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBain</surname><given-names>CJ</given-names></name><name><surname>Mayer</surname><given-names>ML</given-names></name></person-group><article-title><italic>N</italic>-methyl-D-aspartic acid receptor structure and function</article-title><source>Physiol Rev</source><year>1994</year><volume>74</volume><fpage>723</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">8036251</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutel</surname><given-names>V</given-names></name><name><surname>Buchy</surname><given-names>D</given-names></name><name><surname>Klingelschmidt</surname><given-names>A</given-names></name><name><surname>Messer</surname><given-names>J</given-names></name><name><surname>Bleuel</surname><given-names>Z</given-names></name><name><surname>Kemp</surname><given-names>JA</given-names></name><etal/></person-group><article-title><italic>In vitro</italic> binding properties in rat brain of [3H]Ro25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits</article-title><source>J Neurochem</source><year>1998</year><volume>70</volume><fpage>2147</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">9572302</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>WT</given-names></name><name><surname>Kuo</surname><given-names>MF</given-names></name><name><surname>Mishra</surname><given-names>OP</given-names></name><name><surname>Delivoria-Papadopoulos</surname><given-names>M</given-names></name></person-group><article-title>Distribution and expression of the subunits of N-methyl-D-aspartate (NMDA) receptors; NR1, NR2A and NR2B in hypoxic newborn piglet brains</article-title><source>Brain Res</source><year>1998</year><volume>799</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">9666074</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>S</given-names></name><name><surname>Wyatt</surname><given-names>A</given-names></name><name><surname>Webb</surname><given-names>JK</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>R</given-names></name><name><surname>Mason</surname><given-names>G</given-names></name><name><surname>Rigby</surname><given-names>M</given-names></name><etal/></person-group><article-title>Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localisation of NR2B subunit in dorsal horn</article-title><source>Neuropharmacology</source><year>1999</year><volume>38</volume><fpage>611</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">10340299</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>DW</given-names></name><name><surname>Rothman</surname><given-names>SM</given-names></name></person-group><article-title>The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death</article-title><source>Annu Rev Neurosci</source><year>1990</year><volume>13</volume><fpage>171</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">1970230</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>TP</given-names></name><name><surname>Aarts</surname><given-names>M</given-names></name><name><surname>Rooyakkers</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Lai</surname><given-names>TW</given-names></name><etal/></person-group><article-title>NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>2846</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17360906</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kantos</surname><given-names>HA</given-names></name><name><surname>Povlishok</surname><given-names>JT</given-names></name></person-group><article-title>Oxygen radicals in brain injury</article-title><source>Cent Nerv Sys Trauma</source><year>1986</year><volume>3</volume><fpage>257</fpage><lpage>63</lpage></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braugler</surname><given-names>JM</given-names></name><name><surname>Hall</surname><given-names>ED</given-names></name></person-group><article-title>Central nervous system trauma and stroke.Biochemical concentrations for oxygen radical formation and lipid peroxidation</article-title><source>Free Rad Biol Med</source><year>1989</year><volume>6</volume><fpage>289</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">2663662</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewen</surname><given-names>A</given-names></name><name><surname>Matz</surname><given-names>P</given-names></name><name><surname>Chan</surname><given-names>PH</given-names></name></person-group><article-title>Free radical pathways in CNS injury</article-title><source>Neurotrauma</source><year>2000</year><volume>17</volume><fpage>871</fpage><lpage>90</lpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Metabolism and functions of glutathione in brain</article-title><source>Prog Neurobiol</source><year>2000</year><volume>62</volume><fpage>649</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">10880854</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>PH</given-names></name><name><surname>Kawase</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>SF</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Calagui</surname><given-names>B</given-names></name><etal/></person-group><article-title>Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion</article-title><source>J Neurosci</source><year>1998</year><volume>18</volume><fpage>8292</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9763473</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikawa</surname><given-names>S</given-names></name><name><surname>Kinouchi</surname><given-names>H</given-names></name><name><surname>Kamii</surname><given-names>H</given-names></name><name><surname>Gobbel</surname><given-names>GT</given-names></name><name><surname>Chen</surname><given-names>SF</given-names></name><name><surname>Carlson</surname><given-names>E</given-names></name><etal/></person-group><article-title>Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice</article-title><source>J Neurosurg</source><year>1996</year><volume>85</volume><fpage>885</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">8893728</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>P</given-names></name><name><surname>Yamauchi</surname><given-names>T</given-names></name><name><surname>Noble</surname><given-names>LJ</given-names></name><name><surname>Ferriero</surname><given-names>DM</given-names></name></person-group><article-title>Age-dependent differences in glutathione peroxidase activity after traumatic brain injury</article-title><source>J Neurotrauma</source><year>2003</year><volume>20</volume><fpage>437</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">12803976</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Borisenko</surname><given-names>GG</given-names></name><name><surname>Sokolova</surname><given-names>TV</given-names></name><name><surname>Ritov</surname><given-names>VB</given-names></name><name><surname>Quinn</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Oxidative stress following traumatic brain injury in rats: Quantitation of biomarkers and detection of free radical intermediates</article-title><source>J Neurochem</source><year>2000</year><volume>7</volume><fpage>2178</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">11032908</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahib</surname><given-names>MN</given-names></name><name><surname>Syamsunarno</surname><given-names>MR</given-names></name><name><surname>Faried</surname><given-names>A</given-names></name><name><surname>Yuliana</surname><given-names>D</given-names></name><name><surname>Anggraeni</surname><given-names>D</given-names></name><name><surname>Yuniarti</surname><given-names>L</given-names></name><etal/></person-group><article-title>The effect of glycine max extract diets on changes in NR2B gene expression, cognitive vitality and neurotoxicity in high concentrate consumption</article-title><source>Kitakanto Med J</source><year>2010</year><volume>60</volume><fpage>41</fpage><lpage>7</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faried</surname><given-names>A</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Faried</surname><given-names>LS</given-names></name><name><surname>Usman</surname><given-names>N</given-names></name><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><etal/></person-group><article-title>Expression of carbohydrate antigens in human esophageal squamous cell carcinoma: Prognostic application and its diagnostic implication</article-title><source>Ann Surg Oncol</source><year>2006</year><volume>14</volume><fpage>960</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17094023</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feuerstein</surname><given-names>GZ</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Barone</surname><given-names>FC</given-names></name></person-group><article-title>Inflammatory gene expression in cerebral ischemia and trauma.Potential new therapeutic targets</article-title><source>Ann N Y Acad Sci</source><year>1997</year><volume>825</volume><fpage>179</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">9369986</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shohami</surname><given-names>E</given-names></name><name><surname>Beit-Yannai</surname><given-names>E</given-names></name><name><surname>Horowitz</surname><given-names>M</given-names></name><name><surname>Kohen</surname><given-names>R</given-names></name></person-group><article-title>Oxidative stress in closed-head injury: Brain antioxidant capacity as an indicator of functional outcome</article-title><source>J Cereb Blood Flow Metab</source><year>1997</year><volume>17</volume><fpage>1007</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">9346425</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>C</given-names></name><name><surname>Mayo</surname><given-names>JC</given-names></name><name><surname>Sainz</surname><given-names>RM</given-names></name><name><surname>Antol&#x000ed;n</surname><given-names>I</given-names></name><name><surname>Herrera</surname><given-names>F</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>V</given-names></name><etal/></person-group><article-title>Regulation of antioxidant enzyme: A significant role for melatonin</article-title><source>J Pineal Res</source><year>2004</year><volume>36</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14675124</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>E</given-names></name><name><surname>Brooke</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>P</given-names></name><name><surname>Sapolsky</surname><given-names>R</given-names></name></person-group><article-title>Over-expression of antioxidant enzymes protects cultured hippocampal and cortical neurons from necrotic insults</article-title><source>J Neurochem</source><year>2003</year><volume>87</volume><fpage>1527</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">14713308</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>ML</given-names></name><name><surname>Westbrook</surname><given-names>GL</given-names></name></person-group><article-title>Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones</article-title><source>J Physiol</source><year>1987</year><volume>394</volume><fpage>501</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">2451020</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meldrum</surname><given-names>B</given-names></name><name><surname>Garthwaite</surname><given-names>J</given-names></name></person-group><article-title>Excitatory amino acid neurotoxicity and neurodegenerative disease</article-title><source>Trends Pharmacol Sci</source><year>1990</year><volume>11</volume><fpage>379</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">2238094</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascher</surname><given-names>P</given-names></name><name><surname>Nowak</surname><given-names>L</given-names></name></person-group><article-title>The role of divalent cations in the NMDA response of mouse central neurons in culture</article-title><source>J Physiol</source><year>1988</year><volume>399</volume><fpage>247</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">2457089</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>A</given-names></name><name><surname>Miyamoto</surname><given-names>M</given-names></name><name><surname>Kudo</surname><given-names>Y</given-names></name></person-group><article-title>Neural death <italic>in vitro</italic>: Parallelism between survivability of hyppocampal neurons and sustained elevation of cytosolic Ca<sup>2+</sup> after exposure to glutamate receptor agonist</article-title><source>Exp Brain Res</source><year>1988</year><volume>73</volume><fpage>447</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">2906295</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>A</given-names></name></person-group><article-title>Opportunities for neuroprotection in traumatic brain injury</article-title><source>J Head Trauma Rehabil</source><year>2000</year><volume>15</volume><fpage>1149</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">10970935</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>TV</given-names></name><name><surname>Bhatia</surname><given-names>P</given-names></name><name><surname>Sandhu</surname><given-names>K</given-names></name><name><surname>Prabhakar</surname><given-names>T</given-names></name><name><surname>Gogna</surname><given-names>RL</given-names></name></person-group><article-title>Secondary brain injury: Prevention and intensive care management</article-title><source>Indian J Neurotrauma</source><year>2005</year><volume>2</volume><fpage>7</fpage><lpage>12</lpage></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigford</surname><given-names>GE</given-names></name><name><surname>Alonso</surname><given-names>OF</given-names></name><name><surname>Dietrich</surname><given-names>D</given-names></name><name><surname>Keane</surname><given-names>RW</given-names></name></person-group><article-title>A novel protein complex in membrane Rafts lingking the NR2B glutamate receptor and autophagy is disrupted following traumatic brain injury</article-title><source>J Neurotrauma</source><year>2009</year><volume>26</volume><fpage>703</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">19335206</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>AN</given-names></name><name><surname>Fiskum</surname><given-names>G</given-names></name><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Mitochondria in neurodegeneration: Bioenergic function in cell life and death</article-title><source>J Cereb Blood Flow Metab</source><year>1999</year><volume>19</volume><fpage>231</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">10078875</pub-id></element-citation></ref></ref-list></back></article>